New Ray Medicine International Holding Limited reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was HKD 89.77 million compared to HKD 335.38 million a year ago. Net loss was HKD 77.95 million compared to HKD 2.82 million a year ago.

Basic loss per share from continuing operations was HKD 0.0466 compared to HKD 0.0017 a year ago.